Parnax Lab Ltd. (PARNAXLAB)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
133. 55
+0.55
+0.4135%
₹
1.57B Market Cap
- P/E Ratio
- Div Yield
170 Volume
0 Eps
₹ 133
Previous Close Want to track PARNAXLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PARNAXLAB closed today higher at ₹133.55, an increase of 0.4135% from yesterday's close, completing a monthly decrease of -2.0535% or -₹2.8. Over the past 12 months, PARNAXLAB stock gained 2.7308%.
PARNAXLAB is not paying dividends to its shareholders.
The last earnings report, released on Feb 18, 2025, exceeded the consensus estimates by 1.0537%. On average, the company has surpassed earnings expectations by 2.4957%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
PARNAXLAB Chart
People also search for
Parnax Lab Ltd. (PARNAXLAB) FAQ
What is the stock price today?
The current price is ₹133.55.
On which exchange is it traded?
Parnax Lab Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is PARNAXLAB.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.57B.
Has Parnax Lab Ltd. ever had a stock split?
No, there has never been a stock split.
Parnax Lab Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Mihir Prakash Shah CEO | MSE Exchange | INE383L01019 ISIN |
| India Country | 12 Employees | - Last Dividend | - Last Split | - IPO Date |
Parnax Lab Ltd. operates as a pharmaceutical company, primarily engaged in the manufacturing and distribution of a wide array of medicinal products. Its primary function is to provide quality pharmaceutical formulations in diverse therapeutic segments such as antibiotics, analgesics, and multivitamins, which are essential in healthcare and well-being. The company supports both domestic and international markets, supplying products to various regions, thereby playing a crucial role in global health initiatives. Parnax Lab Ltd. is involved in continuous research and development to innovate and enhance its product offerings, focusing on improved drug efficacy and patient safety. As a participant in the pharmaceutical sector, it significantly contributes to the industry by addressing health challenges and meeting rising healthcare demands, thus supporting public health systems worldwide. Established with a commitment to quality and safety, Parnax Lab Ltd. has positioned itself as a trusted name in the pharmaceutical manufacturing landscape.
Contact Information
Address: Bldg. No.8
Phone: 91 22 6825 2525
Website: https://www.naxparlab.com
